{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T20:12:08Z","timestamp":1772223128526,"version":"3.50.1"},"reference-count":22,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,8,29]],"date-time":"2008-08-29T00:00:00Z","timestamp":1219968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2009,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p> <jats:italic>Background:<\/jats:italic> Contact allergy (CA) to topical corticosteroids (CS) is relatively rare; however, current data from Germany are not available. Furthermore, valid risk assessment needs to take into account of the actual exposure to CS in the population.<\/jats:p><jats:p> <jats:italic>Patients and Methods:<\/jats:italic> The reaction profile of 9 CS included in a \u201cCS test battery\u201d of the German Contact Dermatitis Research Group (DKG) in patients seen in German clinics belonging to the Information Network of Departments of Dermatology (IVDK; <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.ivdk.org\">http:\/\/www.ivdk.org<\/jats:ext-link>) between 01\/1995 and 12\/2004 was analyzed. Applying the \u201cClinical Epidemiology\/Drug Utilization Research\u201d approach, annual incidences of CA to CS in Germany were extrapolated. These estimates were used as numerator for a relative incidence (RI) estimate which used exposure in terms of \u201cdefined daily doses\u201d (DDD) to the respective CS as denominator, the latter information collected by the AOK Research Institute (WIdO).<\/jats:p><jats:p> <jats:italic>Results:<\/jats:italic> On average, 7.4% of all patients were patch tested with the CS series, mostly yielding &lt; 1% positive reactions. Exceptions included hydrocortisone 17\u2010butyrate (1.5%), amcinonide (1.6%) and budesonide (2.6%). With a RI of 10.7, 23.6 and 4.9 per 100 000 DDD, respectively, the three CS mentioned classify as moderate topical drug allergens. Clobetasol 17\u2010propionate and triamcinolone acetonide both yielded a RI of 1.4\/100 000 DDD, indicating low sensitization risk. For hydrocortisone, betamethasone, prednisolone and dexamethasone (RI &lt; 1\/100 000 DDD) the risk of sensitization appears minute.<\/jats:p><jats:p> <jats:italic>Conclusions:<\/jats:italic> The results support and extend previous evidence on the CA risk of CS, adding to a therapeutic index and risk assessment.<\/jats:p>","DOI":"10.1111\/j.1610-0387.2008.06844.x","type":"journal-article","created":{"date-parts":[[2008,10,11]],"date-time":"2008-10-11T20:02:49Z","timestamp":1223755369000},"page":"34-41","source":"Crossref","is-referenced-by-count":3,"title":["Contact allergy to topical corticosteroids \u2013 results from the IVDK and epidemiological risk assessment"],"prefix":"10.1111","volume":"7","author":[{"given":"Wolfgang","family":"Uter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiane Menezes","family":"De P\u00e1dua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Pfahlberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Nink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Schnuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Lessmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,12,24]]},"reference":[{"key":"e_1_2_8_2_2","first-page":"75","article-title":"Allergische Reaktionen auf Glukokortikoide","volume":"38","author":"Uter W","year":"1990","journal-title":"Derm Beruf Umwelt"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/3-540-31301-X_35"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2000.00121.x"},{"key":"e_1_2_8_5_2","first-page":"41","article-title":"Recommendation to include budesonide and tixocortol pivalate in the European standard series","volume":"43","author":"Isaksson M","year":"2000","journal-title":"Contact Dermatitis"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2004.00275.x"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2001.440511-6.x"},{"key":"e_1_2_8_8_2","first-page":"116","article-title":"Corticosteroid Contact Dermatitis","volume":"45","author":"Lehmann P","year":"1997","journal-title":"Derm Beruf Umwelt"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2007.06523.x"},{"key":"e_1_2_8_10_2","first-page":"582","article-title":"Der Informationsverbund Dermatologischer Kliniken (IVDK). Klinische Epidemiologie zur Pr\u00e4vention des Allergischen Kontaktekzems. [Information Society of Dermatological Clinics. Clinical epidemiology for prevention of allergic contact eczema]","volume":"52","author":"Schnuch A","year":"2001","journal-title":"Hautarzt"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.5414\/DBP53107"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-1873.2004.00406.x"},{"key":"e_1_2_8_13_2","volume-title":"Statistical methods for rates and proportions","author":"Fleiss JL","year":"1981"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2002.470107.x"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/3-540-30505-X"},{"key":"e_1_2_8_16_2","volume-title":"Methodik der ATC\u2010Klassifikation und DDD\u2010Festlegung. ATC\u2010Index mit DDD\u2010Angaben (CD\u2010ROM)","author":"Fricke U","year":"2005"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1588"},{"key":"e_1_2_8_18_2","volume-title":"Allergic Contact Dermatitis to Topical Drugs \u2013 Epidemiological Risk Assessment","author":"Menezes de Padua CA","year":"2007"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0536.2007.00959.x"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s001050170048"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.5414\/ALP25415"},{"key":"e_1_2_8_22_2","first-page":"369","article-title":"Kreuzreaktionen \/\u201eGruppenallergie\u201c","volume":"1","author":"Uter W","year":"2007","journal-title":"Dustri, Deisenhofen"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0353.2004.03626.x"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1610-0387.2008.06844.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1610-0387.2008.06844.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T11:01:20Z","timestamp":1697454080000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1610-0387.2008.06844.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,24]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["10.1111\/j.1610-0387.2008.06844.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1610-0387.2008.06844.x","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,24]]}}}